| Arkansas Population Profile: Population, Age, Race/Ethnicity Household type, marital status, fertility, educational attainment/enrollment, veteran status, disability status, computer & internet use Employment status, occupation, income, health insurance, poverty status | US Census Bureau, American Community Survey Census – Table Results Census – Table Results Census – Table Results |
| Arkansas Unemployment | Department of Labor, Bureau of Labor Statistics Bureau of Labor Statistics Data (bls.gov) |
| Arkansas Uninsured – state and county | US Census Bureau, American Community Survey Census – Table Results |
| Arkansas Rural Population | US Department of Agriculture, ERS USDA ERS – Rural-Urban Continuum Codes |
| Self Rated Health Status | Behavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC |
| Adult Hypertension | Behavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC |
| Adult High Cholesterol | Behavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC |
| Adult Arthritis | Behavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC |
| Youth Electronic Vapor Product Use | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Youth Age of first cigarette use | Youth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Cigarettes and smokeless tobacco lifetime use | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Cigarettes and smokeless tobacco current use | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Electronic vapor product lifetime use | Youth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Lifetime alcohol use | Arkansas Prevention Needs Assessment/Youth Risk Behavioral Surveillance Survey (YRBSS)** Arkansas Prevention Needs Assessment Survey (pridesurveys.com)Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Average age of first alcohol use | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Current alcohol use | Arkansas Prevention Needs Assessment/Youth Risk Behavioral Surveillance Survey (YRBSS)** Arkansas Prevention Needs Assessment Survey (pridesurveys.com)Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Current binge drinking | Arkansas Prevention Needs Assessment/Youth Risk Behavioral Surveillance Survey (YRBSS)** Arkansas Prevention Needs Assessment Survey (pridesurveys.com)Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Current marijuana use | Arkansas Prevention Needs Assessment/Youth Risk Behavioral Surveillance Survey (YRBSS)** Arkansas Prevention Needs Assessment Survey (pridesurveys.com)Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Lifetime marijuana use | Arkansas Prevention Needs Assessment/Youth Risk Behavioral Surveillance Survey (YRBSS)** Arkansas Prevention Needs Assessment Survey (pridesurveys.com)Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Average age of first marijuana use | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Lifetime prescription drug misuse | Youth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Current prescription drug misuse | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Age of first misuse of prescription drugs | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Youth current drug abuse | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Youth lifetime drug abuse | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Youth lifetime illegal drug injected | Youth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Adult current smokers | Behavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC |
| Smoking 3 months prior to pregnancy | Pregnancy Risk Assessment Monitoring System Prevalence of Selected Maternal and Child Health Indicators for Arkansas, Pregnancy Risk Assessment Monitoring System (PRAMS), 2016-2019 (cdc.gov) |
| Smoking last 3 months of pregnancy | Pregnancy Risk Assessment Monitoring System Prevalence of Selected Maternal and Child Health Indicators for Arkansas, Pregnancy Risk Assessment Monitoring System (PRAMS), 2016-2019 (cdc.gov) |
| Smoking after delivery | Pregnancy Risk Assessment Monitoring System Prevalence of Selected Maternal and Child Health Indicators for Arkansas, Pregnancy Risk Assessment Monitoring System (PRAMS), 2016-2019 (cdc.gov) |
| Alcohol Use 3 months before pregnancy | Pregnancy Risk Assessment Monitoring System Prevalence of Selected Maternal and Child Health Indicators for Arkansas, Pregnancy Risk Assessment Monitoring System (PRAMS), 2016-2019 (cdc.gov) |
| Adult current alcohol use | Behavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC |
| Adult Binge drinking | Behavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC |
| Adult heavy drinking | Behavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC |
| Adult current marijuana use | National Survey on Drug Use and Health SAMHDA (samhsa.gov) |
| Adult past year marijuana use | National Survey on Drug Use and Health SAMHDA (samhsa.gov) |
| Drug related arrests for marijuana/hashish | Arkansas Crime Information Center (ACIC) Crime Statistics – Arkansas Department of Public Safety |
| Drug overdose deaths in the US | Centers for Disease Control 2019 Drug Overdose Death Rates | Drug Overdose | CDC Injury Center |
| Opioid related overdose deaths per 100,000 | Centers for Disease Control 2018-2019 Prescription Opioid Overdose Data | Drug Overdose | CDC Injury Center |
| Opioid prescriptions per 100 persons by county | Centers for Disease Control U.S. County Opioid Dispensing Rates, 2020 | Drug Overdose | CDC Injury Center |
| Adult cocaine use | National Survey on Drug Use and Health SAMHDA (samhsa.gov) |
| Adult methamphetamine use | National Survey on Drug Use and Health SAMHDA (samhsa.gov) |
| Adult illicit drug use in the past 3 months | National Survey on Drug Use and Health SAMHDA (samhsa.gov) |
| Tobacco use during pregnancy | Pregnancy Risk Assessment Monitoring System Prevalence of Selected Maternal and Child Health Indicators for Arkansas, Pregnancy Risk Assessment Monitoring System (PRAMS), 2016-2019 (cdc.gov) |
| Rate of neonatal abstinence syndrome | Arkansas Department of Health, Prescription Monitoring Program Prescription Drug Monitoring Program Arkansas Department of Health |
| Percentage with angina or coronary heart disease | Behavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC |
| Percentage with stroke | Behavioral Risk Factor Surveillance Survey (BRFSS) Behavioral Risk Factor Surveillance System | DPH | CDC |
| Percentage with heart attack | Behavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC |
| Percentage with COPD | Behavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC |
| Age adjusted mortality rate for smoking related cancers, respiratory and cardiovascular diseases* | Centers for Disease Control, Multiple Cause of Death Multiple Cause of Death, 2018-2020, Single Race Results Form (cdc.gov) |
| Age adjusted mortality rate for alcoholic fatty liver disease, ICD10 K70 | Centers for Disease Control Multiple Cause of Death, 2018-2020, Single Race Results Form (cdc.gov) |
| Academic Performance | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Suicide rates in Arkansas | Centers for Disease Control, CDC Wonder Multiple Cause of Death, 2018-2020, Single Race Results Form (cdc.gov) |
| Rate of attempted suicide | Youth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Rate of injurious suicide | Youth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Drug and alcohol related arrests in Arkansas | Arkansas Crime Information Center (ACIC) Crime Statistics – Arkansas Department of Public Safety |
| Alcohol related crash fatalities | US Department of Transportation, Fatality Analysis Reporting System Fatality Analysis Reporting System (FARS) | NHTSA |
| Risk perception – smoking, marijuana, alcohol | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Youth feeling sad or hopeless | Youth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Adult depression | Behavioral Risk Factor Surveillance Survey (BRFSS) BRFSS Prevalence & Trends Data: Explore by Location | DPH | CDC |
| Major depressive episode by age | National Survey on Drug Use and Health SAMHDA (samhsa.gov) |
| Percentage of students protected by religiosity | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Poor mental health in adults | Behavioral Risk Factor Surveillance Survey (BRFSS) Behavioral Risk Factor Surveillance System | DPH | CDC” |
| Parents/Peers with attitudes favorable to drug use | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Students bullied at school | Youth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Students bullied electronically | Youth Risk Behavioral Surveillance Survey (YRBSS)** Youth Online: High School YRBS – T-Test Arkansas 2019 and United States 2019 Results | DASH | CDC |
| Transitions and mobility | Arkansas Prevention Needs Assessment Arkansas Prevention Needs Assessment Survey (pridesurveys.com) |
| Rate of homelessness per 100 children enrolled in Arkansas public schools | Arkansas Department of Education Data Center Statewide Information System Reports (arkansas.gov) |
| Percentage Tobacco sales to minors | Arkansas Tobacco Control Arkansas Tobacco Control Board |
| People in alcohol or drug treatment | Arkansas Department of Human Services Statistical Reports – Arkansas Department of Human Services |
| People needing but not receiving treatment | National Survey on Drug Use and Health SAMHDA (samhsa.gov) |
| Food insecurity | By state, U.S. Department of Agriculture, Economic Research Service foodsecurity_data_file.xlsx (live.com) By county, U.S. Department of Agriculture, Economic Research Service, Food Atlas USDA ERS – Data Access and Documentation Downloads |
| Retail Alcohol Establishments | U.S. Census Bureau, County Business Patterns County Business Patterns (CBP) Tables (census.gov) |
| Disconnected Youth | American Community Survey, Table B14005 Census – Table Results |
| Overcrowded Housing | American Community Survey, Table DP04 Census – Table Results |
| GINI measure of income inequality | American Community Survey Census – Table Results |
* Smoking related cancers include lip, oral cavity, and pharynx; esophagus; stomach; pancreas; larynx; trachea, bronchus, and lung; cervix; bladder; kidney and other urinary tract; and acute myeloid leukemia. Cardiovascular diseases related to smoking include coronary heart disease; other heart disease; cerebrovascular disease; atherosclerosis; aortic aneurysm; and other arterial disease. Smoking related respiratory diseases include pneumonia and influenza; bronchitis and emphysema; and COPD. ICD10 codes include C00.0 (External upper lip – Malignant neoplasms); C00.1 (External lower lip – Malignant neoplasms); C00.2 (External lip, unspecified – Malignant neoplasms); C00.3 (Upper lip, inner aspect – Malignant neoplasms); C00.4 (Lower lip, inner aspect – Malignant neoplasms); C00.5 (Lip, unspecified, inner aspect – Malignant neoplasms); C00.6 (Commissure of lip – Malignant neoplasms); C00.8 (Overlapping lesion of lip – Malignant neoplasms); C00.9 (Lip, unspecified – Malignant neoplasms); C01 (Malignant neoplasm of base of tongue); C02.0 (Dorsal surface of tongue – Malignant neoplasms); C02.1 (Border of tongue – Malignant neoplasms); C02.2 (Ventral surface of tongue – Malignant neoplasms); C02.3 (Anterior two-thirds of tongue, part unspecified – Malignant neoplasms); C02.4 (Lingual tonsil – Malignant neoplasms); C02.8 (Overlapping lesion of tongue – Malignant neoplasms); C02.9 (Tongue, unspecified – Malignant neoplasms); C03.0 (Upper gum – Malignant neoplasms); C03.1 (Lower gum – Malignant neoplasms); C03.9 (Gum, unspecified – Malignant neoplasms); C04.0 (Anterior floor of mouth – Malignant neoplasms); C04.1 (Lateral floor of mouth – Malignant neoplasms); C04.8 (Overlapping lesion of floor of mouth – Malignant neoplasms); C04.9 (Floor of mouth, unspecified – Malignant neoplasms); C05.0 (Hard palate – Malignant neoplasms); C05.1 (Soft palate – Malignant neoplasms); C05.2 (Uvula – Malignant neoplasms); C05.8 (Overlapping lesion of palate – Malignant neoplasms); C05.9 (Palate, unspecified – Malignant neoplasms); C06.0 (Cheek mucosa – Malignant neoplasms); C06.1 (Vestibule of mouth – Malignant neoplasms); C06.2 (Retromolar area – Malignant neoplasms); C06.8 (Overlapping lesion of other and unspecified parts of mouth – Malignant neoplasms); C06.9 (Mouth, unspecified – Malignant neoplasms); C07 (Malignant neoplasm of parotid gland); C08.0 (Submandibular gland – Malignant neoplasms); C08.1 (Sublingual gland – Malignant neoplasms); C08.8 (Overlapping lesion of major salivary glands – Malignant neoplasms); C08.9 (Major salivary gland, unspecified – Malignant neoplasms); C09.0 (Tonsillar fossa – Malignant neoplasms); C09.1 (Tonsillar pillar (anterior)(posterior) – Malignant neoplasms); C09.8 (Overlapping lesion of tonsil – Malignant neoplasms); C09.9 (Tonsil, unspecified – Malignant neoplasms); C10.0 (Vallecula – Malignant neoplasms); C10.1 (Anterior surface of epiglottis – Malignant neoplasms); C10.2 (Lateral wall of oropharynx – Malignant neoplasms); C10.3 (Posterior wall of oropharynx – Malignant neoplasms); C10.4 (Branchial cleft – Malignant neoplasms); C10.8 (Overlapping lesion of oropharynx – Malignant neoplasms); C10.9 (Oropharynx, unspecified – Malignant neoplasms); C11.0 (Superior wall of nasopharynx – Malignant neoplasms); C11.1 (Posterior wall of nasopharynx – Malignant neoplasms); C11.2 (Lateral wall of nasopharynx – Malignant neoplasms); C11.3 (Anterior wall of nasopharynx – Malignant neoplasms); C11.8 (Overlapping lesion of nasopharynx – Malignant neoplasms); C11.9 (Nasopharynx, unspecified – Malignant neoplasms); C12 (Malignant neoplasm of pyriform sinus); C13.0 (Postcricoid region – Malignant neoplasms); C13.1 (Aryepiglottic fold, hypopharyngeal aspect – Malignant neoplasms); C13.2 (Posterior wall of hypopharynx – Malignant neoplasms); C13.8 (Overlapping lesion of hypopharynx – Malignant neoplasms); C13.9 (Hypopharynx, unspecified – Malignant neoplasms); C14.0 (Pharynx, unspecified – Malignant neoplasms); C14.2 (Malignant neoplasm of Waldeyer ring); C14.8 (Overlapping lesion of lip, oral cavity and pharynx – Malignant neoplasms); C15.0 (Cervical part of oesophagus – Malignant neoplasms); C15.1 (Thoracic part of oesophagus – Malignant neoplasms); C15.2 (Abdominal part of oesophagus – Malignant neoplasms); C15.3 (Upper third of oesophagus – Malignant neoplasms); C15.4 (Middle third of oesophagus – Malignant neoplasms); C15.5 (Lower third of oesophagus – Malignant neoplasms); C15.8 (Overlapping lesion of oesophagus – Malignant neoplasms); C15.9 (Oesophagus, unspecified – Malignant neoplasms); C16.0 (Cardia – Malignant neoplasms); C16.1 (Fundus of stomach – Malignant neoplasms); C16.2 (Body of stomach – Malignant neoplasms); C16.3 (Pyloric antrum – Malignant neoplasms); C16.4 (Pylorus – Malignant neoplasms); C16.5 (Lesser curvature of stomach, unspecified – Malignant neoplasms); C16.6 (Greater curvature of stomach, unspecified – Malignant neoplasms); C16.8 (Overlapping lesion of stomach – Malignant neoplasms); C16.9 (Stomach, unspecified – Malignant neoplasms); C25.0 (Head of pancreas – Malignant neoplasms); C25.1 (Body of pancreas – Malignant neoplasms); C25.2 (Tail of pancreas – Malignant neoplasms); C25.3 (Pancreatic duct – Malignant neoplasms); C25.4 (Endocrine pancreas – Malignant neoplasms); C25.7 (Other parts of pancreas – Malignant neoplasms); C25.8 (Overlapping lesion of pancreas – Malignant neoplasms); C25.9 (Pancreas, unspecified – Malignant neoplasms); C32.0 (Glottis – Malignant neoplasms); C32.1 (Supraglottis – Malignant neoplasms); C32.2 (Subglottis – Malignant neoplasms); C32.3 (Laryngeal cartilage – Malignant neoplasms); C32.8 (Overlapping lesion of larynx – Malignant neoplasms); C32.9 (Larynx, unspecified – Malignant neoplasms); C33 (Malignant neoplasm of trachea); C34.0 (Main bronchus – Malignant neoplasms); C34.1 (Upper lobe, bronchus or lung – Malignant neoplasms); C34.2 (Middle lobe, bronchus or lung – Malignant neoplasms); C34.3 (Lower lobe, bronchus or lung – Malignant neoplasms); C34.8 (Overlapping lesion of bronchus and lung – Malignant neoplasms); C34.9 (Bronchus or lung, unspecified – Malignant neoplasms); C53.0 (Endocervix – Malignant neoplasms); C53.1 (Exocervix – Malignant neoplasms); C53.8 (Overlapping lesion of cervix uteri – Malignant neoplasms); C53.9 (Cervix uteri, unspecified – Malignant neoplasms); C64 (Malignant neoplasm of kidney, except renal pelvis); C67.0 (Trigone of bladder – Malignant neoplasms); C67.1 (Dome of bladder – Malignant neoplasms); C67.2 (Lateral wall of bladder – Malignant neoplasms); C67.3 (Anterior wall of bladder – Malignant neoplasms); C67.4 (Posterior wall of bladder – Malignant neoplasms); C67.5 (Bladder neck – Malignant neoplasms); C67.6 (Ureteric orifice – Malignant neoplasms); C67.7 (Urachus – Malignant neoplasms); C67.8 (Overlapping lesion of bladder – Malignant neoplasms); C67.9 (Bladder, unspecified – Malignant neoplasms); C68.0 (Urethra – Malignant neoplasms); C68.1 (Paraurethral gland – Malignant neoplasms); C68.8 (Overlapping lesion of urinary organs – Malignant neoplasms); C68.9 (Urinary organ, unspecified – Malignant neoplasms); C92.0 (Acute myeloid leukaemia – Malignant neoplasms); I25.1 (Atherosclerotic heart disease); I25.8 (Other forms of chronic ischaemic heart disease); I60-I69 (Cerebrovascular diseases); I70.0 (Atherosclerosis of aorta); I70.1 (Atherosclerosis of renal artery); I70.2 (Atherosclerosis of arteries of extremities); I70.8 (Atherosclerosis of other arteries); I70.9 (Generalized and unspecified atherosclerosis); I71.0 (Dissection of aorta [any part]); I71.1 (Thoracic aortic aneurysm, ruptured); I71.2 (Thoracic aortic aneurysm, without mention of rupture); I71.3 (Abdominal aortic aneurysm, ruptured); I71.4 (Abdominal aortic aneurysm, without mention of rupture); I71.5 (Thoracoabdominal aortic aneurysm, ruptured); I71.6 (Thoracoabdominal aortic aneurysm, without mention of rupture); I71.8 (Aortic aneurysm of unspecified site, ruptured); I71.9 (Aortic aneurysm of unspecified site, without mention of rupture); I77.8 (Other specified disorders of arteries and arterioles); J09-J18 (Influenza and pneumonia); J20.0 (Acute bronchitis due to Mycoplasma pneumoniae); J20.1 (Acute bronchitis due to Haemophilus influenzae); J20.2 (Acute bronchitis due to streptococcus); J20.3 (Acute bronchitis due to coxsackievirus); J20.4 (Acute bronchitis due to parainfluenza virus); J20.5 (Acute bronchitis due to respiratory syncytial virus); J20.6 (Acute bronchitis due to rhinovirus); J20.7 (Acute bronchitis due to echovirus); J20.8 (Acute bronchitis due to other specified organisms); J20.9 (Acute bronchitis, unspecified); J43.0 (MacLeod syndrome); J43.1 (Panlobular emphysema); J43.2 (Centrilobular emphysema); J43.8 (Other emphysema); J43.9 (Emphysema, unspecified); J44.0 (Chronic obstructive pulmonary disease with acute lower respiratory infection); J44.1 (Chronic obstructive pulmonary disease with acute exacerbation, unspecified); J44.8 (Other specified chronic obstructive pulmonary disease); J44.9 (Chronic obstructive pulmonary disease, unspecified)
** The YRBSS is conducted every other year (2017, 2019, 2021, etc.)